Our results showed that in LNN patients with ERα-positive primary tumours who had not received systemic adjuvant treatment, high mRNA levels of NCOR2 and CITED2 were associated with a longer MFS independently of the traditional prognostic factors. The gene discussed is CITED2; the disease is neoplasm.